Prevalence of alcohol and other drug detections in non‐transport injury events

Georgina Lau, Biswadev Mitra, Belinda J. Gabbe, Paul Dietze, Sandra Reeder, Peter Cameron, De Villiers Smit, Hans G. Schneider, Evan Symons, Christine Koolstra, Cara Stewart, Ben BeckEmergency 2023 · DOI

TL;DR

This study investigated the prevalence of alcohol and other drug (AOD) use in patients presenting to a major trauma center with non-transport injuries. The findings reveal a significant AOD detection rate, particularly in cases of interpersonal violence and intentional self-harm, underscoring the need for broader public health strategies to address AOD use as a risk factor for injury.

What Problem Does This Paper Address?

While significant public health efforts have focused on reducing alcohol and drug-related harms in transport injuries (like impaired driving), the role of AODs in non-transport injuries (such as falls, violence, and self-harm) has been less understood. These non-transport injuries constitute a substantial portion of major trauma cases. Existing data on AOD prevalence in these injury types often comes from international studies, which may not accurately reflect Australian contexts due to differing regulations, AOD use cultures, and availability of substances. This paper aims to provide up-to-date prevalence estimates of AOD detections in non-transport injury events within a major Australian trauma center, filling a critical knowledge gap for evidence-informed prevention strategies.

Methods

The researchers conducted a registry-based cohort study using data from The Alfred Hospital's Emergency and Trauma Centre. They included adult patients (≥18 years) who sustained non-transport injuries and met predefined trauma call-out criteria between July 2021 and December 2022. AOD detection prevalence was measured through routine in-hospital blood alcohol concentration (BAC) and urine drug screens. BAC was measured using an alcohol dehydrogenase method, and urine drug screens were analyzed by immunoassay, with results reported as "detected" or "not detected" for specific drug classes (cannabinoids, benzodiazepines, amphetamine-type substances, opioids, and cocaine). The study also considered prescription drug use and defined "high alcohol hours" (Friday/Saturday nights) to analyze temporal patterns.

Datasets

The study utilized data from The Alfred Hospital Trauma Registry, encompassing patient demographics, injury event details (cause, intent, time/date), hospital characteristics, and AOD test results.

Key Insights and Ideas

  • AODs are a significant factor in non-transport injuries: The study highlights that AODs are not just associated with transport injuries but are also prevalent in a substantial proportion of non-transport injury events presenting to major trauma centers.
  • Specific injury types show higher AOD prevalence: Interpersonal violence and intentional self-harm cases had notably higher rates of AOD detections, suggesting a strong link between substance use and these specific injury intents.
  • Temporal patterns matter: Alcohol use was more prevalent during "high alcohol hours" (Friday and Saturday nights), reinforcing the need for targeted interventions during these periods.
  • Biological samples offer robust data: The use of blood and urine samples provides a more sensitive measure of AOD involvement compared to administrative coding, though it also introduces potential limitations related to detection windows.

Key Results

  • A total of 1469 cases met the inclusion criteria.
  • Of patients with a blood alcohol test (n=1248), 25.1% tested positive for alcohol.
  • Of patients with a urine drug screen (n=733), 31.1% tested positive for drugs other than alcohol.
  • Overall, 37.4% of patients with either a blood alcohol or urine drug test completed had at least one AOD detection.
  • AOD detections were most prevalent in cases of interpersonal violence (68.7%) and intentional self-harm (47.2%).
  • Cannabinoids were the most commonly detected illicit drug (14.1%), followed by benzodiazepines (13.4%) and amphetamine-type substances (10.9%).
  • Alcohol was particularly common in injuries occurring on Friday and Saturday nights (51.5%).

Limitations and Future Work

The authors acknowledge several limitations:

  • Time delays: The time between injury and hospital presentation could lead to a decline in AOD levels, potentially underestimating prevalence at the time of injury.
  • Limited drug classes: Urine drug screens were limited to six drug classes, potentially missing other relevant substances.
  • Overestimation potential: It's possible that AOD testing was more likely for clinically intoxicated patients, and urine samples have a longer detection window, potentially capturing AOD use unrelated to the injury event.
  • Prescription drug data: The study could not determine if prescription drugs were used as recommended.
  • Single-site study: Findings may not be generalizable to other trauma centers.
  • Exclusion of less severe injuries: AOD testing was restricted to trauma call-out criteria, limiting generalizability to less severe injuries.

Future work should focus on:

  • Population-level surveillance: Establishing systems to monitor AOD use in all injury events to inform prevention strategies.
  • Quantifying risk: Better quantifying the risk of various non-transport injury causes associated with AOD use.
  • Understanding interactions: Improving understanding of the interplay between AOD use, risk-taking behavior, and injury risk.
  • Exploring alternative testing: Considering blood samples as a potentially more accurate measure due to their tighter detection window.

Summary updated

Abstract

AOD detections were common in trauma patients with non-transport injury causes. Population-level surveillance is needed to inform prevention strategies that address AOD use as a significant risk factor for serious injury.
BibTeX
@inproceedings{lau2023prevalence,
  author = {Georgina Lau and Biswadev Mitra and Belinda J. Gabbe and Paul Dietze and Sandra Reeder and Peter Cameron and De Villiers Smit and Hans G. Schneider and Evan Symons and Christine Koolstra and Cara Stewart and Ben Beck},
  title = {{Prevalence of alcohol and other drug detections in non‐transport injury events}},
  booktitle = {Emergency},
  year = {2023},
  doi = {10.1111/1742-6723.14312},
}
Figure